Home » Newsletters » BioWorld

BioWorld

Aug. 31, 1993

View Archived Issues

FDA PANEL RECOMMENDS ONCOR'S HPV TEST

CANGUARD RAISES $324,000

SEQUANA PARTNERSHIP TO MAP GENES

'INTRIGUING' ANTIPODAL ANTI-HIV DRUG

CELL THERAPY ON YOUTH WITH IFSH

GENZYME AWARDED PATENT FOR RGCR

AMGEN, KIRIN TO SELL EPO AND G-CSF IN CHINA

ALLELIX, GLAXO IN JOINT VENTURE

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...